Hologic Inc (HOLX)
80.82
+0.72
(+0.90%)
USD |
NASDAQ |
Sep 27, 16:00
80.85
+0.03
(+0.04%)
After-Hours: 20:00
Hologic Research and Development Expense (Annual): 294.30M for Sept. 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 294.30M |
| September 30, 2022 | 283.40M |
| September 30, 2021 | 276.30M |
| September 30, 2020 | 222.50M |
| September 30, 2019 | 232.20M |
| September 30, 2018 | 218.70M |
| September 30, 2017 | 232.80M |
| September 30, 2016 | 232.10M |
| September 30, 2015 | 214.90M |
| September 30, 2014 | 203.20M |
| September 30, 2013 | 197.60M |
| September 30, 2012 | 131.00M |
| September 30, 2011 | 116.70M |
| September 30, 2010 | 104.30M |
| September 30, 2009 | 102.45M |
| Date | Value |
|---|---|
| September 30, 2008 | 81.42M |
| September 30, 2007 | 44.48M |
| September 30, 2006 | 28.29M |
| September 30, 2005 | 18.62M |
| September 30, 2004 | 16.66M |
| September 30, 2003 | 18.38M |
| September 30, 2002 | 20.36M |
| September 30, 2001 | 23.33M |
| September 30, 2000 | 17.18M |
| September 30, 1999 | 12.70M |
| September 30, 1998 | 9.80M |
| September 30, 1997 | 8.50M |
| September 30, 1996 | 7.30M |
| September 30, 1995 | 4.30M |
| September 30, 1994 | 3.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
222.50M
Minimum
2020
294.30M
Maximum
2023
261.74M
Average
276.30M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Universal Health Services Inc | -- |
| Nuwellis Inc | 5.422M |
| Varex Imaging Corp | 84.80M |
| Quanterix Corp | 24.86M |